>>Description of the research protocol "B-Will"

B-Will study: National Survey of Von Willebrand Disease in Belgium
Status : Ongoing and recruiting

Additional details

Indication (or studied pathology) : Hématologie
Brugmann identifier : B-Will
EudraCT identifier : B300201112301


Involved department : Hemato-oncology
Principal investigator : Nifosi
Sponsor : UZ Antwerpen
Contact : Clinical Research Unit

>This protocol was approved by the UZ Antwerpen ethics committee.